Zhan Y, Zhang K, Fan Y, Lin S, Wu J, Xu H
Int J Clin Pharm. 2025; .
PMID: 39821006
DOI: 10.1007/s11096-025-01866-7.
Shi F, Ergashev A, Pan Z, Sun H, Kong L, Jin Y
Mater Today Bio. 2025; 30():101406.
PMID: 39816666
PMC: 11733200.
DOI: 10.1016/j.mtbio.2024.101406.
Liu C, Reger M, Fan H, Wang J, Zhang J
Br J Cancer. 2024; 132(3):266-275.
PMID: 39681617
PMC: 11791052.
DOI: 10.1038/s41416-024-02929-8.
Huang P, Gao W, Fu C, Wang M, Li Y, Chu B
Nature. 2024; 637(8046):726-735.
PMID: 39537929
DOI: 10.1038/s41586-024-08225-y.
Briones-Andrade J, Ramirez-Santiago G, Romero-Arias J
R Soc Open Sci. 2024; 11(10):240702.
PMID: 39493299
PMC: 11528534.
DOI: 10.1098/rsos.240702.
Inflammatory Processes: Key Mediators of Oncogenesis and Progression in Pancreatic Ductal Adenocarcinoma (PDAC).
Yang L, Qiao S, Zhang G, Lu A, Li F
Int J Mol Sci. 2024; 25(20).
PMID: 39456771
PMC: 11506938.
DOI: 10.3390/ijms252010991.
Altered immune cell in human severe acute pancreatitis revealed by single-cell RNA sequencing.
Wu Z, Wang S, Wu Z, Tao J, Li L, Zheng C
Front Immunol. 2024; 15:1354926.
PMID: 39372399
PMC: 11449708.
DOI: 10.3389/fimmu.2024.1354926.
Allelic effects on expression likely mediated by JunB/D underlie a PDAC GWAS signal at chr1p36.33.
Connelly K, Hullin K, Abdolalizadeh E, Zhong J, Eiser D, OBrien A
medRxiv. 2024; .
PMID: 39371158
PMC: 11451706.
DOI: 10.1101/2024.09.16.24313748.
Pancreatic Cancer: A Review of Risk Factors.
Grigorescu R, Husar-Sburlan I, Gheorghe C
Life (Basel). 2024; 14(8).
PMID: 39202722
PMC: 11355429.
DOI: 10.3390/life14080980.
Regulatory axis of circular RNA DTNB, microRNA-485-5p, and myeloid cell leukemia 1 attenuates inflammation and apoptosis in caerulein-treated AR42J cells.
Tian X, Zhang Y, Peng M, Hou Y
Funct Integr Genomics. 2024; 24(5):140.
PMID: 39160285
DOI: 10.1007/s10142-024-01411-1.
Anakinra-Loaded Sphingomyelin Nanosystems Modulate In Vitro IL-1-Dependent Pro-Tumor Inflammation in Pancreatic Cancer.
Abal-Sanisidro M, De Luca M, Roma S, Ceraolo M, Fuente M, De Monte L
Int J Mol Sci. 2024; 25(15).
PMID: 39125655
PMC: 11312284.
DOI: 10.3390/ijms25158085.
A real-world disproportionality analysis of semaglutide: Post-marketing pharmacovigilance data.
Du Y, Zhang M, Wang Z, Hu M, Xie D, Wang X
J Diabetes Investig. 2024; 15(10):1422-1433.
PMID: 38943656
PMC: 11442840.
DOI: 10.1111/jdi.14229.
Type I conventional dendritic cells facilitate immunotherapy in pancreatic cancer.
Mahadevan K, Dyevoich A, Chen Y, Li B, Sugimoto H, Sockwell A
Science. 2024; 384(6703):eadh4567.
PMID: 38935717
PMC: 11841451.
DOI: 10.1126/science.adh4567.
Autophagy and inflammation an intricate affair in the management of obesity and metabolic disorders: evidence for novel pharmacological strategies?.
Friuli M, Sepe C, Panza E, Travelli C, Paterniti I, Romano A
Front Pharmacol. 2024; 15:1407336.
PMID: 38895630
PMC: 11184060.
DOI: 10.3389/fphar.2024.1407336.
The Use of Glucagon-like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes Mellitus Does Not Increase the Risk of Pancreatic Cancer: A U.S.-Based Cohort Study.
Ayoub M, Faris C, Juranovic T, Chela H, Daglilar E
Cancers (Basel). 2024; 16(9).
PMID: 38730578
PMC: 11082986.
DOI: 10.3390/cancers16091625.
Analysis of immune cell infiltration characteristics in severe acute pancreatitis through integrated bioinformatics.
Xiao S, Han X, Bai S, Chen R
Sci Rep. 2024; 14(1):8711.
PMID: 38622245
PMC: 11018854.
DOI: 10.1038/s41598-024-59205-1.
Blocking CIRP protects against acute pancreatitis by improving mitochondrial function and suppressing pyroptosis in acinar cells.
Liu W, Ren Y, Wang T, Wang M, Xu Y, Zhang J
Cell Death Discov. 2024; 10(1):156.
PMID: 38538578
PMC: 10973482.
DOI: 10.1038/s41420-024-01923-6.
Lifestyle Medicine for the Prevention and Treatment of Pancreatitis and Pancreatic Cancer.
Subramanian S, Brahmbhatt B, Bailey-Lundberg J, Thosani N, Mutha P
Diagnostics (Basel). 2024; 14(6).
PMID: 38535034
PMC: 10968821.
DOI: 10.3390/diagnostics14060614.
Leucine rich repeat LGI family member 3: Integrative analyses support its prognostic association with pancreatic adenocarcinoma.
Yun H
Medicine (Baltimore). 2024; 103(8):e37183.
PMID: 38394487
PMC: 11309673.
DOI: 10.1097/MD.0000000000037183.
Mechanism exploration and biomarker identification of glycemic deterioration in patients with diseases of the exocrine pancreas.
Wang Z, Zhang G, Fu J, Li G, Zhao Z, Choe H
Sci Rep. 2024; 14(1):4374.
PMID: 38388766
PMC: 10883946.
DOI: 10.1038/s41598-024-52956-x.